primary immunodeficiency

PINSA POSITION STATEMENT ON ACCESS TO IMMUNOGLOBULIN THERAPIES FOR PATIENTS LIVING WITH A PRIMARY IMMUNODEFICIENCY

PINSA POSITION STATEMENT ON ACCESS TO IMMUNOGLOBULIN THERAPIES FOR PATIENTS LIVING WITH A PRIMARY IMMUNODEFICIENCY

ByPiNSA

July 2014 This PiNSA statement supports international calls to ensure access to the best suited immunoglobulin (IG) replacement therapy, as prescribed by physicians for patients living with a primary immunodeficiency (PID)[1] that requires IG replacement therapy. It is estimated that there are between 20,000- 40,000 South Africans living with PID, of whom 99% remain undiagnosed….